Skip to main content
Top

20-08-2015 | Psoriatic arthritis | Review | Article

Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence

Journal: Current Rheumatology Reports

Authors: Alexis Ogdie, J. M. Gelfand

Publisher: Springer US

Abstract

Psoriatic arthritis (PsA), a chronic inflammatory arthritis, affects about 10 % of patients with psoriasis with higher prevalence seen in patients with more extensive skin disease. Early identification of PsA may result in improved outcomes. While it remains unclear which patients with psoriasis will develop PsA, several studies have identified potential risk factors for PsA among patients with psoriasis. This review examines the basic epidemiologic principles of identifying risk factors and reviews the evidence to date about risk factors for PsA among patients with psoriasis.
Literature
1.
Kurd S, Gelfand J. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003–2004. J Am Acad Dermatol. 2009;60(2):218–24.CrossRefPubMed
2.
Alamanos Y, Voulgari P, Drosos A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35(7):1354–8.PubMed
3.
Ibrahim G, Waxman R, Helliwell P. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009;61(10):1373–8.CrossRefPubMed
4.
Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573.PubMed
5.
Ogdie A, Langan S, Love T, et al. Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford). 2013;52(3):568–75.CrossRef
6.
Mease P, Gladman D, Papp K, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–35.CrossRefPubMed
7.•
Fitzgerald O, Haroon M, Giles JT, Winchester R. Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther. 2015;17(1):115. While our review discusses the clinical risk factors for PsA, this is an excellent review of the genetic risk factors for psoriatic arthritis and the interplay between genotypes and phenotypes in psoriatic arthritis. PubMedCentralCrossRefPubMed
8.
Fletcher RH, Fletcher SW, Fletcher GS. Risk: basic principles. In: clinical epidemiology: the essentials. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2014. p. 50–79.
9.
Simon L. Pharmacovigilance: towards a better understanding of the benefit to risk ratio. Ann Rheum Dis. 2002;61(2):ii88–9.PubMedCentralCrossRefPubMed
10.
Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.PubMedCentralPubMed
11.
Ogdie A, Weiss PF. Epidemiology of Psoriatic Arthritis. Rheum Dis Clin North Am 2015; In Press.
12.
Wu S, Han J, Qureshi AA. Use of aspirin, non-steroidal anti-inflammatory drugs, and acetaminophen (paracetamol), and risk of psoriasis and psoriatic arthritis: a cohort study. Acta Derm Venereol. 2015;95(2):217–23.PubMedCentralCrossRefPubMed
13.••
Wu S, Li WQ, Han J, Sun Q, Qureshi AA. Hypercholesterolemia and risk of incident psoriasis and psoriatic arthritis in US women. Arthrit Rheumatol. 2014;66(2):304–10. In this retrospective cohort study, Wu et al. found an increased incidence of both psoriasis and psoriatic arthritis among patients with physician-diagnosed hypercholesterolemia. In contrast, there was no association with cholesterol-lowering medications. CrossRef
14.
Tong LX, Wu S, Li T, Qureshi AA, Giovannucci EL, Cho E. Personal history of gallstones and risk of incident psoriasis and psoriatic arthritis in U.S. women. Br J Dermatol. 2015;172(5):1316–22.PubMedCentralCrossRefPubMed
15.
Haroon M, Kirby B, FitzGerald O. High prevalence of psoriatic arthritis in patients with severe psoriasis with suboptimal performance of screening questionnaires. Ann Rheum Dis. 2013;72(5):736–40.CrossRefPubMed
16.
Gelfand J, Gladman D, Mease P, et al. Epidemiology of psoriatic arthritis in the population of the US. 2005; 53:573–7.
17.
Wilson F, Icen M, Crowson C, McEvoy M, Gabriel S, Kremers H. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum. 2009;61(2):233–9.PubMedCentralCrossRefPubMed
18.
Soltani-Arabshahi R, Wong B, Feng B, Goldgar D, Duffin K, Krueger G. Obesity in early adulthood as a risk factor for psoriatic arthritis. Arch Dermatol. 2010;146(7):721–6.CrossRefPubMed
19.
Tey H, Ee H, Tan A, Theng T, Wong S, Khoo S. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol. 2010;37(5):426–30.CrossRefPubMed
20.
Anandarajah A, Ritchlin C. Pathogenesis of psoriatic arthritis. Curr Opin Rheumatol. 2004;16(4):338–43.CrossRefPubMed
21.
Ferrándiz C, Pujol RM, García-Patos V, Bordas X, Smandía JA. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol. 2002;46(6):867–73.CrossRefPubMed
22.
Stuart P, Malick F, Nair RP, et al. Analysis of phenotypic variation in psoriasis as a function of age at onset and family history. Arch Dermatol Res. 2002;294(5):207–13.CrossRefPubMed
23.
McGonagle D, Palmou Fontana N, Tan A, Benjamin M. Nailing down the genetic and immunological basis for psoriatic disease. Dermatology. 2010;221 Suppl 1:15–22.CrossRefPubMed
24.
Love T, Gudjonsson J, Valdimarsson H, Gudbjornsson B. Psoriatic arthritis and onycholysis—results from the cross-sectional Reykjavik psoriatic arthritis study. J Rheumatol. 2012;39(7):1441–4.CrossRefPubMed
25.
Scarpa R, Soscia E, Peluso R, et al. Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol. 2006;33(7):1315–9.PubMed
26.
Thumboo J, Uramoto K, Shbeeb M, et al. Risk factors for the development of psoriatic arthritis: a population based nested case control study. J Rheumatol. 2002;29(4):757–62.PubMed
27.
Thijssen E, van Caam A, van der Kraan P. Obesity and osteoarthritis, more than just wear and tear: pivotal roles for inflamed adipose tissue anddyslipidaemia in obesity-induced osteoarthritis. Rheumatology (Oxford). 2015;54(4):588–600.CrossRef
28.
Kumar S, Han J, Li T, Curhan G, Choi HK, Qureshi AA. Obesity, waist circumference, weight change, and the risk of psoriasis in US women. J Eur Acad Dermatol Venereol. 2013;27(10):1293–8.PubMedCentralPubMed
29.
Love T, Zhu Y, Zhang Y, et al. Obesity and the risk of psoriatic arthritis: a population-based study. Ann Rheum Dis. 2012;71(8):1273–7.PubMedCentralCrossRefPubMed
30.
Li W, Han J, Qureshi A. Obesity and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(8):1267–772.PubMedCentralCrossRefPubMed
31.
Ogdie A, Gelfand JM. Identification of risk factors for psoriatic arthritis: scientific opportunity meets clinical need. Arch Dermatol. 2010;146(7):785–8.PubMedCentralCrossRefPubMed
32.
Setty A, Curhan G, Choi H. Smoking and the risk of psoriasis in women: Nurses’ Health Study II. Am J Med. 2007;120(11):953–9.PubMedCentralCrossRefPubMed
33.
Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69(1):70–81.CrossRefPubMed
34.
Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis. 2012;71(2):219–24.CrossRefPubMed
35.
Eder L, Law T, Chandran V, et al. Association between environmental factors and onset of psoriatic arthritis in patients with psoriasis. Arthritis Care Res (Hoboken). 2011;63(8):1091–7.CrossRef
36.
Pattison E, Harrison B, Griffiths C, Silman A, Bruce I. Environmental risk factors for the development of psoriatic arthritis: results from a case–control study. Ann Rheum Dis. 2008;67(5):627–6.
37.
Li W, Han J, Qureshi A. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis. 2012;71(6):804–8.PubMedCentralCrossRefPubMed
38.
Wu S, Cho E, Li WQ, Han J, Qureshi AA. Alcohol intake and risk of incident psoriatic arthritis in women. J Rheumatol. 2015;42(5):835–40.CrossRefPubMed
39.
Scott I, Tan R, Stahl D, Steer S, Lewis C, Cope A. The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52(5):856–67.CrossRef
40.
McGonagle D, Ash Z, Dickie L, McDermott M, Aydin S. The early phase of psoriatic arthritis. Ann Rheum Dis. 2011;70 Suppl 1:i71–6.CrossRefPubMed
41.•
Manasson J, Scher J. Spondyloarthritis and the microbiome: new insights from an ancient hypothesis. Curr Rheumatol Rep. 2015;17(2):10. This review paper highlights the potential role of the microbiome (both the intestinal and skin microbiome) in the development of the spondyloarthropathies. CrossRefPubMed
42.•
Eder L, Chandran V, Shen H. Incidence of arthritis in a prospective cohort of psoriasis patients. Arthritis Care Res (Hoboken). 2011;63(4):619–22. Describes the first prospective longitudinal study to examine the incidence of PsA among patients with psoriasis. CrossRef